Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12998/wjcc.v8.i8.1385 http://scihub22266oqcxt.onion/10.12998/wjcc.v8.i8.1385 32368531!7190951!32368531     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Clin+Cases 2020 ; 8 (8): 1385-1390 Nephropedia Template TP {{tp|p=32368531|t=2020. Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis |pdf=|usr=}}{{32368531}} gab.com Text Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis JO: World J Clin Cases http://www.kidney.de/pget.php?&tw=1&pmid=32368531 #FOAvip In patients infected with severe acute respiratory syndrome coronavirus 2, the respiratory symptoms, such as fever, cough and dyspnea, are the most frequent clinical manifestations. These patients may also present with less well-defined symptoms like diarrhea, nausea, vomiting and/or abdominal discomfort both at the time of diagnosis and during the clinical course. In a few cases, these symptoms may also present before the appearance of respiratory symptoms. To penetrate the body, Severe acute respiratory syndrome coronavirus 2 uses ACE2 receptors, which are present not only in respiratory epithelium but also in gastrointestinal mucosa and liver cholangiocytes. In several cases, viral RNA is detectable in the stool of patients with coronavirus disease 2019 (COVID-19). The liver damage seems to show a multifactorial origin. About 2%-11% of patients with COVID-19 have known underlying hepatic pathologies. In 14%-53% of COVID-19 cases, there is an alteration of the indices of liver cytolysis and is more frequently observed in severe forms of COVID-19, especially during hospitalization. Twit Text FOAVip Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis ????World J Clin Cases http://www.kidney.de/pget.php?&tw=1&pmid=32368531 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32368531 #FOAvip English Wikipedia <ref>{{Cite pmid|32368531}}</ref> Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis #MMPMID32368531 Zippi M; Fiorino S; Occhigrossi G; Hong W World J Clin Cases 2020[Apr]; 8 (8): 1385-1390 PMID32368531show ga In patients infected with severe acute respiratory syndrome coronavirus 2, the respiratory symptoms, such as fever, cough and dyspnea, are the most frequent clinical manifestations. These patients may also present with less well-defined symptoms like diarrhea, nausea, vomiting and/or abdominal discomfort both at the time of diagnosis and during the clinical course. In a few cases, these symptoms may also present before the appearance of respiratory symptoms. To penetrate the body, Severe acute respiratory syndrome coronavirus 2 uses ACE2 receptors, which are present not only in respiratory epithelium but also in gastrointestinal mucosa and liver cholangiocytes. In several cases, viral RNA is detectable in the stool of patients with coronavirus disease 2019 (COVID-19). The liver damage seems to show a multifactorial origin. About 2%-11% of patients with COVID-19 have known underlying hepatic pathologies. In 14%-53% of COVID-19 cases, there is an alteration of the indices of liver cytolysis and is more frequently observed in severe forms of COVID-19, especially during hospitalization. äHypertransaminasemia in the course of infection with SARS-CoV-2: Incid(epmc).pdf DeepDyve Pubget Overpricing